Ian Mortimer has been named chief financial officer of biopharmaceutical firm Xenon.

Mortimer previously served as CFO of Tekmira Pharmaceuticals. Before that, he was CFO of Tekmira predecessor Inex Pharmaceuticals.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harvard Medical School's George Church discusses editing human DNA, including germline DNA, in the New England Journal of Medicine.

According to Nature News, the African Academy of Sciences is launching an open-access publishing platform next year.

A new report suggests the UK's stature in science and research could fall post-Brexit, the Guardian reports.

In Nature this week: genome sequence of wheat progenitor Aegilops tauschii, and more.